Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Weilunte Pharmaceutical Technology is a specialized pharmaceutical technology company based in Guangzhou, China, focusing on the research, development, and production of high-end pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs). The company is particularly recognized for its expertise in nucleoside and nucleotide chemistry, providing critical building blocks for antiviral and anticancer medications. Weilunte offers a range of services including custom synthesis, process optimization, and contract manufacturing (CDMO) for global pharmaceutical partners. Their facilities are equipped to handle complex chemical transformations, supporting drug development from laboratory scale to commercial production. The company serves a diverse clientele, ranging from innovative biotech startups to established multinational pharmaceutical corporations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Weilunte Pharmaceutical Technology.